ET
COGT icon

Entropy Technologies’s Cogent Biosciences COGT Stock Holding History

Entropy Technologies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,638
Closed -$89.7K – 759
2024
Q2 		$89.7K Sell
10,638
-20,994
-66% -$159K 0.01% 636
2024
Q1 		$213K Buy
+31,632
New +$196K 0.02% 647

Other funds holding COGT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Entropy Technologies's COGT Position: Q3 2024 in Review

Entropy Technologies sold out of Cogent Biosciences (COGT) in Q3 2024, closing a stake of 10,638 shares — an estimated $89.7K sold.

Entropy Technologies first reported a position in COGT in Q1 2024 and held it in 2 quarters. The position peaked at $213K in Q1 2024. 161 funds tracked by Wall St. Rank hold COGT as of Q3 2024.

  • Entropy Technologies reported no remaining Cogent Biosciences position as of Q3 2024 after selling out during the quarter.
  • Entropy Technologies sold 10,638 Cogent Biosciences shares in Q3 2024, an estimated $89.7K.
  • Entropy Technologies first reported a position in Cogent Biosciences in Q1 2024 and held it in 2 quarters.
  • Entropy Technologies's Cogent Biosciences position peaked at $213K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2024.

Based on Entropy Technologies's 13F filing for Q3 2024, filed 4 Nov 2024.